Concepedia

Betty Peng

BP

Statistics

Publications

12

Citations

484

H-Index

11

Active since

2007

Affiliations

Gilead Sciences (United States)(Current)

Betty Peng is an author at Gilead Sciences (United States) specializing in molecular virology, virology, and viral hepatitis.

Publications per year

2007–2016

12

Publications

12

Mechanistic Characterization of GS-9190 (Tegobuvir), a Novel Nonnucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase

I‐hung Shih, Inge Vliegen, Betty Peng et al. · Antimicrobial Agents and Chemotherapy · 2011 · 90 citations · Full text

, , +17

<i>In Vitro</i> Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir

Guofeng Cheng, Tian Yang, Brian Doehle et al. · Antimicrobial Agents and Chemotherapy · 2016 · 69 citations · Full text

, , +17

1191 GS-5816, A SECOND GENERATION HCV NS5A INHIBITOR WITH POTENT ANTIVIRAL ACTIVITY, BROAD GENOTYPIC COVERAGE AND A HIGH RESISTANCE BARRIER

Guofeng Cheng, Ming‐Jiun Yu, Betty Peng et al. · Journal of Hepatology · 2013 · 51 citations · Full text

, , +14

Novel Hepatitis C Virus Reporter Replicon Cell Lines Enable Efficient Antiviral Screening against Genotype 1a

Margaret Robinson, Huiling Yang, Siu-Chi Chang Sun et al. · Antimicrobial Agents and Chemotherapy · 2010 · 51 citations · Full text

, , +15

Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent <i>C</i> -Nucleoside Monophosphate Prodrug

Joy Y. Feng, Guofeng Cheng, Jason K. Perry et al. · Antimicrobial Agents and Chemotherapy · 2014 · 41 citations · Full text

, , +17

1–5 of 12